Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis

ABSTRACT Meningitis and encephalitis are leading causes of central nervous system (CNS) disease and often result in severe neurological compromise or death. Traditional diagnostic workflows largely rely on pathogen-specific tests, sometimes over days to weeks, whereas metagenomic next-generation seq...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anne Piantadosi, Shibani S. Mukerji, Simon Ye, Michael J. Leone, Lisa M. Freimark, Daniel Park, Gordon Adams, Jacob Lemieux, Sanjat Kanjilal, Isaac H. Solomon, Asim A. Ahmed, Robert Goldstein, Vijay Ganesh, Bridget Ostrem, Kaelyn C. Cummins, Jesse M. Thon, Cormac M. Kinsella, Eric Rosenberg, Matthew P. Frosch, Marcia B. Goldberg, Tracey A. Cho, Pardis Sabeti
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/257d13788e6c45d0b65f5a35776fbd4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:257d13788e6c45d0b65f5a35776fbd4c
record_format dspace
spelling oai:doaj.org-article:257d13788e6c45d0b65f5a35776fbd4c2021-11-10T18:37:51ZEnhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis10.1128/mBio.01143-212150-7511https://doaj.org/article/257d13788e6c45d0b65f5a35776fbd4c2021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01143-21https://doaj.org/toc/2150-7511ABSTRACT Meningitis and encephalitis are leading causes of central nervous system (CNS) disease and often result in severe neurological compromise or death. Traditional diagnostic workflows largely rely on pathogen-specific tests, sometimes over days to weeks, whereas metagenomic next-generation sequencing (mNGS) profiles all nucleic acid in a sample. In this single-center, prospective study, 68 hospitalized patients with known (n = 44) or suspected (n = 24) CNS infections underwent mNGS from RNA and DNA to identify potential pathogens and also targeted sequencing of viruses using hybrid capture. Using a computational metagenomic classification pipeline based on KrakenUniq and BLAST, we detected pathogen nucleic acid in cerebrospinal fluid (CSF) from 22 subjects, 3 of whom had no clinical diagnosis by routine workup. Among subjects diagnosed with infection by serology and/or peripheral samples, we demonstrated the utility of mNGS to detect pathogen nucleic acid in CSF, importantly for the Ixodes scapularis tick-borne pathogens Powassan virus, Borrelia burgdorferi, and Anaplasma phagocytophilum. We also evaluated two methods to enhance the detection of viral nucleic acid, hybrid capture and methylated DNA depletion. Hybrid capture nearly universally increased viral read recovery. Although results for methylated DNA depletion were mixed, it allowed the detection of varicella-zoster virus DNA in two samples that were negative by standard mNGS. Overall, mNGS is a promising approach that can test for multiple pathogens simultaneously, with efficacy similar to that of pathogen-specific tests, and can uncover geographically relevant infectious CNS disease, such as tick-borne infections in New England. With further laboratory and computational enhancements, mNGS may become a mainstay of workup for encephalitis and meningitis. IMPORTANCE Meningitis and encephalitis are leading global causes of central nervous system (CNS) disability and mortality. Current diagnostic workflows remain inefficient, requiring costly pathogen-specific assays and sometimes invasive surgical procedures. Despite intensive diagnostic efforts, 40 to 60% of people with meningitis or encephalitis have no clear cause of CNS disease identified. As diagnostic uncertainty often leads to costly inappropriate therapies, the need for novel pathogen detection methods is paramount. Metagenomic next-generation sequencing (mNGS) offers the unique opportunity to circumvent these challenges using unbiased laboratory and computational methods. Here, we performed comprehensive mNGS from 68 prospectively enrolled patients with known (n = 44) or suspected (n = 24) CNS viral infection from a single center in New England and evaluated enhanced methods to improve the detection of CNS pathogens, including those not traditionally identified in the CNS by nucleic acid detection. Overall, our work helps elucidate how mNGS can become integrated into the diagnostic toolkit for CNS infections.Anne PiantadosiShibani S. MukerjiSimon YeMichael J. LeoneLisa M. FreimarkDaniel ParkGordon AdamsJacob LemieuxSanjat KanjilalIsaac H. SolomonAsim A. AhmedRobert GoldsteinVijay GaneshBridget OstremKaelyn C. CumminsJesse M. ThonCormac M. KinsellaEric RosenbergMatthew P. FroschMarcia B. GoldbergTracey A. ChoPardis SabetiAmerican Society for Microbiologyarticleencephalitismetagenomic sequencingnext-generation sequencing (NGS)meningitisvirushybrid captureMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic encephalitis
metagenomic sequencing
next-generation sequencing (NGS)
meningitis
virus
hybrid capture
Microbiology
QR1-502
spellingShingle encephalitis
metagenomic sequencing
next-generation sequencing (NGS)
meningitis
virus
hybrid capture
Microbiology
QR1-502
Anne Piantadosi
Shibani S. Mukerji
Simon Ye
Michael J. Leone
Lisa M. Freimark
Daniel Park
Gordon Adams
Jacob Lemieux
Sanjat Kanjilal
Isaac H. Solomon
Asim A. Ahmed
Robert Goldstein
Vijay Ganesh
Bridget Ostrem
Kaelyn C. Cummins
Jesse M. Thon
Cormac M. Kinsella
Eric Rosenberg
Matthew P. Frosch
Marcia B. Goldberg
Tracey A. Cho
Pardis Sabeti
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
description ABSTRACT Meningitis and encephalitis are leading causes of central nervous system (CNS) disease and often result in severe neurological compromise or death. Traditional diagnostic workflows largely rely on pathogen-specific tests, sometimes over days to weeks, whereas metagenomic next-generation sequencing (mNGS) profiles all nucleic acid in a sample. In this single-center, prospective study, 68 hospitalized patients with known (n = 44) or suspected (n = 24) CNS infections underwent mNGS from RNA and DNA to identify potential pathogens and also targeted sequencing of viruses using hybrid capture. Using a computational metagenomic classification pipeline based on KrakenUniq and BLAST, we detected pathogen nucleic acid in cerebrospinal fluid (CSF) from 22 subjects, 3 of whom had no clinical diagnosis by routine workup. Among subjects diagnosed with infection by serology and/or peripheral samples, we demonstrated the utility of mNGS to detect pathogen nucleic acid in CSF, importantly for the Ixodes scapularis tick-borne pathogens Powassan virus, Borrelia burgdorferi, and Anaplasma phagocytophilum. We also evaluated two methods to enhance the detection of viral nucleic acid, hybrid capture and methylated DNA depletion. Hybrid capture nearly universally increased viral read recovery. Although results for methylated DNA depletion were mixed, it allowed the detection of varicella-zoster virus DNA in two samples that were negative by standard mNGS. Overall, mNGS is a promising approach that can test for multiple pathogens simultaneously, with efficacy similar to that of pathogen-specific tests, and can uncover geographically relevant infectious CNS disease, such as tick-borne infections in New England. With further laboratory and computational enhancements, mNGS may become a mainstay of workup for encephalitis and meningitis. IMPORTANCE Meningitis and encephalitis are leading global causes of central nervous system (CNS) disability and mortality. Current diagnostic workflows remain inefficient, requiring costly pathogen-specific assays and sometimes invasive surgical procedures. Despite intensive diagnostic efforts, 40 to 60% of people with meningitis or encephalitis have no clear cause of CNS disease identified. As diagnostic uncertainty often leads to costly inappropriate therapies, the need for novel pathogen detection methods is paramount. Metagenomic next-generation sequencing (mNGS) offers the unique opportunity to circumvent these challenges using unbiased laboratory and computational methods. Here, we performed comprehensive mNGS from 68 prospectively enrolled patients with known (n = 44) or suspected (n = 24) CNS viral infection from a single center in New England and evaluated enhanced methods to improve the detection of CNS pathogens, including those not traditionally identified in the CNS by nucleic acid detection. Overall, our work helps elucidate how mNGS can become integrated into the diagnostic toolkit for CNS infections.
format article
author Anne Piantadosi
Shibani S. Mukerji
Simon Ye
Michael J. Leone
Lisa M. Freimark
Daniel Park
Gordon Adams
Jacob Lemieux
Sanjat Kanjilal
Isaac H. Solomon
Asim A. Ahmed
Robert Goldstein
Vijay Ganesh
Bridget Ostrem
Kaelyn C. Cummins
Jesse M. Thon
Cormac M. Kinsella
Eric Rosenberg
Matthew P. Frosch
Marcia B. Goldberg
Tracey A. Cho
Pardis Sabeti
author_facet Anne Piantadosi
Shibani S. Mukerji
Simon Ye
Michael J. Leone
Lisa M. Freimark
Daniel Park
Gordon Adams
Jacob Lemieux
Sanjat Kanjilal
Isaac H. Solomon
Asim A. Ahmed
Robert Goldstein
Vijay Ganesh
Bridget Ostrem
Kaelyn C. Cummins
Jesse M. Thon
Cormac M. Kinsella
Eric Rosenberg
Matthew P. Frosch
Marcia B. Goldberg
Tracey A. Cho
Pardis Sabeti
author_sort Anne Piantadosi
title Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
title_short Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
title_full Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
title_fullStr Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
title_full_unstemmed Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and Encephalitis
title_sort enhanced virus detection and metagenomic sequencing in patients with meningitis and encephalitis
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/257d13788e6c45d0b65f5a35776fbd4c
work_keys_str_mv AT annepiantadosi enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT shibanismukerji enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT simonye enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT michaeljleone enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT lisamfreimark enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT danielpark enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT gordonadams enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT jacoblemieux enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT sanjatkanjilal enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT isaachsolomon enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT asimaahmed enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT robertgoldstein enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT vijayganesh enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT bridgetostrem enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT kaelynccummins enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT jessemthon enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT cormacmkinsella enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT ericrosenberg enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT matthewpfrosch enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT marciabgoldberg enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT traceyacho enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
AT pardissabeti enhancedvirusdetectionandmetagenomicsequencinginpatientswithmeningitisandencephalitis
_version_ 1718439759527804928